Lecture 4. Special chemistry Definition Special Chemistry is a subsection of the Chemistry Laboratory of the Division of Clinical Pathology. This includes.

Slides:



Advertisements
Similar presentations
Dr. Amal S. Ahmed Ass Prof.Clinical Pathology Suez Canal University
Advertisements

1 Lecture | Dr. Usman Ghani
TUMOR MARKERS Prof. Dr.Yıldız DİNÇER.
Tumor Markers Lecture one By Dr. Reem Sallam. Objectives  To briefly introduce cancers, their incidence, some common terms, and staging system.  To.
Isoenzymes and Other Markers Mike Clark, M.D.. Isozymes (also known as isoenzymes) are enzymes that differ in amino acid sequence but catalyze the same.
Doç.Dr. Jale Çoban Klinik Biyokimya Uzmanı
Enzymes in Body Fluids Lecture outline
Tumor Markers Lecture one By Dr. Waheed Al-Harizi.
Chemical Composition of Blood Plasma Terms. Mechanics of investigation. High- and low- MW compounds of bl.pl. Interpretation of investigations in clinical.
Tumor Markers Michael A. Pesce, PhD Department of Pathology Columbia-Presbyterian Medical Center.
OnSite Troponin I Rapid Test. Cardiac markers are biomarkers measured to evaluate heart function.biomarkers They are often discussed in the context of.
Myocardial infarction biomarkers Lecture 5. Cases 1 Middle aged man referred by family doctor to a dermatologist because of extensive yellow papules with.
By : dr. samer zahran. Key words myocardium : heart muscle coronary arteries : three major blood vessels supplying blood and oxygen to the heart muscles.
Enzymes in Clinical Diagnosis
Plasma proteins Lecture 3.
Liver function tests Lecture 3.
Eleni Galani Medical Oncologist
Tumor Markers: Clinical Usefulness
Tumor Markers By: dr. hassan el-banna.
Biomarkers Andrew McNaught BME. What is a biomarker? Gives us the ability to analyze organ function, diagnose diseases in a non-invasive way. Biomarkers.
بسم الله الرحمن الرحيم.
Biochemical Markers of Myocardial Infarction
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,
EKUSILENI CLINICAL LABORATORY
Tumor Markers Lecture two By Dr. Reem Sallam. Objectives  To briefly enumerate the most commonly used methods to test for tumor markers  To describe.
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
OF COLOREATAL CANCER USING SEROLOGIC TUMOR MARKERS DIAGNOSIS & MANAGEMENT.
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Biochemical markers in disease diagnosis
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Tumormarkers.
Tumor Markers.
CA-125 Cancer Antigen-125 Discovered in l981
6/2/2016Naglaa Alhusseini1 TUMOR MARKERS Naglaa Fathy Alhusseini Ass.Prof. of Biochemistry and Molecular Biology
Amino-Terminal Pro-Brain Natriuretic Peptide, Brain Natriuretic Peptide, and Troponin T for Prediction of Mortality in Acute Heart Failure.
Enzyme Clinical Application
Tumor Markers American cancer society British Journal of Cancer By B.Heidari.
Biochemical Investigations In Heart Disaeses
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
Laboratory Diagnosis of Cancer 1.Histological methods 2.Cytopathology - FNAC/Exfoliative 3.Immunohistochemistry/ EM 4.Molecular diagnosis 5.Tumor Markers.
Enzymes, Cardiac Markers, Hepatic Tests clinically useful enzymes: tissue sources preanalytical variables affecting enzyme activities isoenzymes myocardial.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Chapter 19 Tumor Markers Zou Xiong. DEFINITIONS-1 Tumor markers originally were defined as substances that can be measured quantitatively by immunochemical.
Cardiac Function.
Biochemical markers for diagnosis and follow up of disease
Tumor Markers.
Biochemical Markers of Myocardial Infarction
Biochemical Markers for Diagnosis of Myocardial Infarction
Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis-antigen.
Khadija Balubaid KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (BIOC 416) 2013 Liver Function profile (LFT) Enzymes.
Unit 6: Tumor markers. Introduction… Cancer is the second leading cause of death in North America, accounting for > 2.7 million deaths annually Although.
Zoe Ryan Carcinoembryonic Antigen (CEA). What is CEA? Carcinoembryonic antigen is a protein found in the blood of some adults who have certain cancers.
Determination of plasma enzymes
Tumor markers Definition Cancer Carcinogenic agents, Endocrine factors Oncogenic viruses, and Ionizing radiation Metastasis Main tumor markers CEA, AFP,
Common pitfall in Oncology Luangyot Thongthieang, MD MEDICAL ONCOLOGY UNIT INTERNAL MEDICINE, KHONKAEN HOSPITAL.
Tumor markers 1111.
How Is Chemotherapy Used to Treat Cancer?
SURGICAL ONCOLOGY AND TUMOR MARKERS
What is it? How is it treated? What makes a person susceptible to it?
Enzymes in the Diagnosis of Pathology
Biochemical Investigations In Heart Disaeses
Biochemistry MI Biomarkers Important. Extra Information.
Isoenzymes Multiple forms of an enzyme which differ in physical and chemical properties and catalyze the same reaction as an enzyme. Isoenzymes are produced.
Interpretation Of LAB Data
biochemical markers for diagnosis and follow up of diseases
Biochemical markers for diagnosis of diseases and follow up
ד"ר שרית בר ששת בי"ח בילינסון
Cardiac enzymes and cardiac proteins
Biochemical Markers of Myocardial Infarction
Cardiac profile test.
Biochemical markers for diagnosis of diseases and follow up
Presentation transcript:

Lecture 4

Special chemistry Definition Special Chemistry is a subsection of the Chemistry Laboratory of the Division of Clinical Pathology. This includes the tests which are not the part of the routine panel.  Electrophoresis  Urine chemistry  Radioimmunoassay.

Test Sensitivity and specificity Troponin test The most sensitive and specific test for myocardial damage. Because it has increased specificity compared with CK-MB, troponin is a superior marker for myocardial injury. Myoglobin (Mb) low specificity for myocardial infarction. Rises very early within 1-3 hours of pain. Pro-brain natriuretic peptide (pro-BNP) This is increased in patients with heart failure. It has been approved as a marker for acute congestive heart failure Glycogen phosphorylase isoenzyme BB high sensitivity and specificity early after chest pain. by ELISA Normal troponin levels 12 hours after chest pain has started mean a heart attack is unlikely

Myloperoxidase (MPO)  Elevated in chronic conditions CRP  Marker of atherosclerosis Pregnancy associated plasma protein A (PAPPA)  elevated in atherosclerosis when atheroma is about to rupture Oxidized LDL  A marker of atherosclerosis Choline  Test of prognosis  Rises in chest discomfort even without rise in troponin level.

Tumour markers A substance produced by tumour or by the host in response to tumour from normal tissues. May be present in blood, urine or tissues. Mostly they are antigens May be cytoplasmic proteins, enzymes and hormones.

uses  Screening  Example: elevated prostate specific antigen suggests prostate cancer.  Monitoring of cancer survivors after treatment. Example: elevated AFP  Diagnosis of specific tumor types, particularly in certain brain tumors and other instances where biopsy is not feasible

Be specific to the tumor Level should change in response to tumor size An abnormal level should be obtained in the presence of micrometastases The level should not have large fluctuations that are independent of changes in tumor size Levels in healthy individuals are at much lower concentrations than those found in cancer patients Predict recurrences before they are clinically detectable Test should be cost effective Ideal tumour marker

SCREENING TESTS Cancer must be common The natural history of the cancer should be understood Effective treatments must be available The test must be acceptable to both patients and physicians The test must be safe and relatively inexpensive

GUIDELINES FOR ORDERING/ INTERPRETING TUMOR MARKER TESTS Never rely on the result of a single test Order every test from the same laboratory Consider half-life of the tumor marker when interpreting the result. Consider how the Tumor Marker is removed or metabolized Consider Hook Effect Consider presence of HAMA antibodies

Detection techniques

Detection technique Tumor markers can be detected by immunohistochemistry Tissue selection Fixation. Tisue slicing by microtome. Antigen antibody reaction. Antibodies are labeled with some substance for detection enzyme, flurophore etc. Amplification

COMMON TUMOR MARKERS AnalyteCancer Use CEAMonitor colorectal, breast, lung cancer CA-125Ovarian cancer monitoring AFPGerm cell tumors, liver cancer Total PSA Screen and monitor prostate cancer Free PSADistinguish prostate cancer from BPH HCGGerm cell and trophoblastic tumors Hormone receptor Breast cancer therapy

Benign conditions leading to high tumour marker level MarkerAssociated nonmalignant conditions AFPViral hepatitis, liver injury, IBD, pregnancy β-hCGTesticular failure, pregnancy CEA Smokers, IBD, hepatitis, cirrhosis, pancreatitis,gastritis CA 125 Peritoneal irritation, endometriosis, pelvic inflammatory disease, hepatitis, pregnancy PAP / PSAProstatitis, benign prostatic hyperplasia

CEA Described by Gold and Freedman in 1965 as a marker for Colorectal Cancer Glycoprotein with a carbohydrate composition ranging from % of molecular mass CEA levels times upper limit of normal suggests colon cancer CEA is not used to screen for colon cancer

AFP Tumour marker of hepatocellular carcinoma, as well as in the acute and chronic hepatitis. Level is less than 10 ng/ml. In person with no liver disease level upto 400ng/ml means liver cancer. But in patients with infections levels upto 4000ng/ml means liver cancer. If tumour is removed fully with surgery then its level should go back to normal. After surgery if level rises again then it means that tumour is back.

Tumor-associatedProteinsImmunoglobulins, markersβ-2M EnzymesLactate dehydrogenase, alkaline phosphatase, pteridines, pterines Acute-phaseC-reactive protein, proteinsferritin InflammatoryESR, viscosity makers UltrastructuralIntermediateDesmin, vimentin componentsfilament components